A novel imaging technology to grade tumor biopsies has been developed by a team of scientists, eradicating human subjectivity and ensuring patients get the correct treatment.
Browsing: Taxonomy > Personalized medicine
Cancer drugs tested on replicas of tumors could provide information on how individual patients will respond to treatment.
The American Society of Clinical Oncology (ASCO) has named adoptive cell immunotherapy as their clinical cancer Advance of the Year.
Discover the importance of DNA methylation changes in the identification of potential biomarkers relevant for clinical follow-up and personalized medicine of chronic lymphocytic leukemia.
How can ASCO’s CancerLinQ help us manage the vast amount of data required to provide high-quality cancer care?
In a first of its kind study, blood sample analysis detects genomic alterations that can predict which cancer patients should receive checkpoint inhibitor immunotherapy.
In this review article, the current knowledge of miRNAs and colorectal cancer diagnosis, prognosis and novel or evolving therapeutic concepts are discussed.
In this editorial from Future Science OA, discover the role that nanotechnology could play in driving personalized medicine for cancer forwards.